Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
Titel:
Therapeutic benefit of the dual ALK/FAK inhibitor ESK440 in ALK-driven neuroblastoma
Auteur:
Chugh, Seema Tien, Jean C. Hon, Jennifer Kenum, Carson Mannan, Rahul Cheng, Yunhui Li, Chi Chiang Taher, Zainab I. Delekta, Andrew D. Bawa, Pushpinder Singh Apel, Ingrid J. Miner, Stephanie J. Cao, Xuhong Mehra, Rohit Dhanasekaran, Saravana M. Qiao, Yuanyuan Mody, Rajen Chinnaiyan, Arul M.